Home / Dabigatran Etexilate / Sweden
SE ATC B01AE07 · updated 2 Nov 2026
Dabigatran Etexilate shortage in Sweden
Is there a Dabigatran Etexilate shortage in Sweden?
Yes. As of 2 Nov 2026, 5 Dabigatran Etexilate products are reported short in Sweden, the first since 25 Jan 2024. The company estimate for the return is 24 Dec 2026 (latest 15 Jan 2027). Main reason: not stated.
Also short in Canada, Germany, Italy, Spain, Austria, Belgium, Czechia, Norway, Australia. All countries.
Affected products in Sweden
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| SE | Dabigatran Etexilate Accord 110 mg Blister, 10 x 1 kapslar (endos) | Accord Healthcare S.L.U. | 25 Jan 2024 | 31 Dec 2026 | Not stated |
| SE | Dabigatran Etexilate Accord 75 mg Blister, 60 x 1 kapslar (endos) | Accord Healthcare S.L.U. | 24 Jul 2024 | not given | Not stated |
| SE | Dabigatran etexilate Krka 150 mg Blister, 180 (3 x 60 x 1) kapslar (endos) | Krka d.d., Novo mesto | 19 Mar 2026 | 24 Dec 2026 | Not stated |
| SE | Dabigatran etexilate Medical Valley 75 mg Blister, 60 kapslar (Al) | Medical Valley Invest AB | 26 Mar 2026 | 31 Dec 2026 | Not stated |
| SE | Dabigatran etexilate Glenmark 75 mg Blister, 60 kapslar | Glenmark Arzneimittel GmbH | 9 Oct 2026 | 15 Jan 2027 | Not stated |
Source
Läkemedelsverket (Swedish Medical Products Agency). Official list. Ongoing and announced shortages (restanmälningar) reported by companies; one row per pack.